Positive data from Larimar Therapeutics, Inc.'s phase 2 study on nomlabofusp for Friedreich's Ataxia suggests growth in the ...

Innovent Biologics (IVBIY) secures second Chinese approval for lung cancer therapy Dovbleron developed with U.S. biotech ...

Discover the health benefits, best and worst ways to consume chia seeds, and how to incorporate them into your diet safely ...

Please enjoy the AgFunder ranking of the top 15 agtech deals of 2024 for startups in the upstream supply chain ...

Of the 503 stocks in the S&P 500 (some companies have two classes of stocks that are included) fewer than 30% of them, or 148 ...

Uncertainty regarding whether Trump will actually impose the tariffs he has proposed is a matter of intense speculation.

Healthcare costs are expected to decline over the next decade due to digital health platforms and cost-effective medical ...

Health insurance premiums are projected to rise by 10-15% in 2025 due to increasing medical costs, higher claims frequency, ...

Loyal, a US biotech startup, has been conducting research and development on LOY-002, a potential drug for extending the ...

Berkshire Hathaway returned to load up on one particular tech stock. Meanwhile, other insiders bought shares of a pair of ...

As part of the IPO, Fabtech plans to issue up to 32,64,000 fresh equity shares, each with a face value of ₹10.